STAR Financial Bank Lowers Stock Holdings in Zoetis Inc. (NYSE:ZTS)

STAR Financial Bank lessened its stake in Zoetis Inc. (NYSE:ZTS) by 8.1% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,511 shares of the company’s stock after selling 222 shares during the period. STAR Financial Bank’s holdings in Zoetis were worth $435,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in ZTS. Greenwood Gearhart Inc. purchased a new stake in shares of Zoetis during the second quarter worth approximately $200,000. Biltmore Family Office LLC increased its stake in Zoetis by 8.1% in the 2nd quarter. Biltmore Family Office LLC now owns 1,686 shares of the company’s stock valued at $292,000 after buying an additional 126 shares during the period. AGF Management Ltd. raised its position in Zoetis by 40.9% during the 2nd quarter. AGF Management Ltd. now owns 573,472 shares of the company’s stock worth $99,417,000 after buying an additional 166,368 shares during the last quarter. Angeles Wealth Management LLC raised its position in Zoetis by 7.8% during the 2nd quarter. Angeles Wealth Management LLC now owns 1,834 shares of the company’s stock worth $318,000 after buying an additional 132 shares during the last quarter. Finally, Steigerwald Gordon & Koch Inc. lifted its stake in shares of Zoetis by 12.1% in the 2nd quarter. Steigerwald Gordon & Koch Inc. now owns 108,987 shares of the company’s stock worth $18,894,000 after acquiring an additional 11,743 shares during the period. 92.80% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on ZTS. BTIG Research increased their price target on shares of Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, August 12th. Piper Sandler raised their price objective on shares of Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, August 14th. Argus upgraded shares of Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. Finally, Stifel Nicolaus reiterated a “buy” rating and set a $200.00 price target on shares of Zoetis in a research report on Tuesday, August 27th. Nine research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $217.11.

Zoetis Price Performance

Shares of NYSE:ZTS opened at $191.37 on Wednesday. The company has a market cap of $86.70 billion, a P/E ratio of 36.87, a P/E/G ratio of 2.90 and a beta of 0.88. The business has a fifty day simple moving average of $181.93 and a 200-day simple moving average of $174.31. Zoetis Inc. has a 52 week low of $144.80 and a 52 week high of $201.92. The company has a quick ratio of 2.09, a current ratio of 3.45 and a debt-to-equity ratio of 1.32.

Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.49 by $0.07. Zoetis had a return on equity of 50.67% and a net margin of 26.29%. The firm had revenue of $2.36 billion for the quarter, compared to analyst estimates of $2.31 billion. During the same period last year, the company earned $1.41 EPS. The firm’s quarterly revenue was up 8.3% on a year-over-year basis. Equities research analysts forecast that Zoetis Inc. will post 5.84 EPS for the current year.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.